drugset / Trial / NCT01195324

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

NCT01195324

RandomizedCrossoverOpen-label

Summary

The purpose of the study is to assess the effect of multiple oral doses of canagliflozin on a single oral dose of warfarin.

Timeline

Start
2010-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CANAGLIFLOZIN ANHYDROUS Small molecule 300 mg Oral
Subject Warfarin Small molecule 30 mg Oral

Indications

No indication recorded.